Page last updated: 2024-08-25

almagate and von Hippel-Lindau Disease

almagate has been researched along with von Hippel-Lindau Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chew, EY; Cusick, M; Dahr, SS; Ferris, FL; Linehan, WM; Rodriguez-Coleman, H; Srivastava, SK; Thompson, DJ	1

Trials

1 trial(s) available for almagate and von Hippel-Lindau Disease

Article	Year
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina (Philadelphia, Pa.), 2007, Volume: 27, Issue:2 Topics: Adult; Aptamers, Nucleotide; Female; Fluorescein Angiography; Hemangioma, Capillary; Humans; Injections; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Neoplasms; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body; von Hippel-Lindau Disease	2007

Article

Year

Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.

Retina (Philadelphia, Pa.), 2007, Volume: 27, Issue:2

Topics: Adult; Aptamers, Nucleotide; Female; Fluorescein Angiography; Hemangioma, Capillary; Humans; Injections; Male; Middle Aged; Pilot Projects; Prospective Studies; Retinal Neoplasms; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body; von Hippel-Lindau Disease

2007